T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
First Industrial Realty Trust
FR
$8.4B
| $135M | 0.02% |
4,076,617
-300,109
| -7% | -$11.9M |
|
|
AAN.A
502
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $134M | 0.02% |
5,889,884
+180,630
| +3% | +$4.11M |
|
503
Expeditors International
EXPD
$24.3B
| $133M | 0.02% |
1,993,433
+74,891
| +4% | +$5.34M |
|
504
Hartford Financial Services
HIG
$37.8B
| $133M | 0.02% |
3,765,300
+3,100,457
| +466% | +$162M |
|
505
Brink's
BCO
$4.72B
| $131M | 0.02% |
2,522,195
-315,475
| -11% | -$24.7M |
|
|
KRTX
506
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $131M | 0.02% |
1,819,943
+1,088,336
| +149% | +$93.1M |
|
507
Nucor
NUE
$61.8B
| $130M | 0.02% |
3,619,189
-1,142,883
| -24% | -$50.7M |
|
|
EQC
508
DELISTED
Equity Commonwealth
EQC
| $129M | 0.02% |
4,079,915
-617,452
| -13% | -$19.8M |
|
509
Guardant Health
GH
$21.4B
| $128M | 0.02% |
1,839,810
-1,260,464
| -41% | -$96.7M |
|
510
Halliburton
HAL
$27.4B
| $128M | 0.02% |
18,668,629
-5,310,028
| -22% | -$92.4M |
|
|
AGN
511
DELISTED
Allergan plc
AGN
| $128M | 0.02% |
721,666
-1,698,878
| -70% | -$320M |
|
|
AEPPL
512
DELISTED
American Electric Power Company, Inc. Corporate Unit
AEPPL
| $128M | 0.02% |
2,653,765
+298,592
| +13% | +$16.1M |
|
513
Blackrock
BLK
$183B
| $127M | 0.02% |
288,811
+18,291
| +7% | +$9.01M |
|
514
iRhythm Holdings
IRTC
$4.06B
| $126M | 0.02% |
1,551,259
+105,854
| +7% | +$8.78M |
|
515
Selective Insurance
SIGI
$5.59B
| $126M | 0.02% |
2,539,054
+148,495
| +6% | +$9.03M |
|
516
Duke Energy
DUK
$97.1B
| $126M | 0.02% |
1,552,095
+115,247
| +8% | +$10.6M |
|
|
CLR
517
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $125M | 0.02% |
16,425,529
+5,041,512
| +44% | +$112M |
|
518
Columbia Banking Systems
COLB
$9.18B
| $123M | 0.02% |
4,600,055
+274,939
| +6% | +$9.66M |
|
519
Knight Transportation
KNX
$11.9B
| $122M | 0.02% |
3,734,138
+1,410,715
| +61% | +$49.9M |
|
520
Kraft Heinz
KHC
$30.1B
| $122M | 0.02% |
4,924,487
+3,770,478
| +327% | +$103M |
|
521
Prosperity Bancshares
PB
$8.97B
| $121M | 0.02% |
2,504,088
-25,018
| -1% | -$1.63M |
|
522
Sunstone Hotel Investors
SHO
$2.02B
| $121M | 0.02% |
13,840,473
+2,524,227
| +22% | +$29.4M |
|
523
PagerDuty
PD
$932M
| $120M | 0.02% |
6,971,458
-326,819
| -4% | -$6.94M |
|
524
Matsons
MATX
$6.39B
| $120M | 0.02% |
3,906,579
-24,055
| -0.6% | -$851K |
|
525
BioMarin Pharmaceuticals
BMRN
$13.3B
| $119M | 0.02% |
1,413,908
-702,146
| -33% | -$60.5M |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.